Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - ROPER TECHNOLOGIES INCFinancial_Report.xls
EX-32.1 - ROPER TECHNOLOGIES INCex32-1.htm
EX-31.2 - ROPER TECHNOLOGIES INCex31-2.htm
EX-31.1 - ROPER TECHNOLOGIES INCex31-1.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 10-Q


[X] QUARTERLY  REPORT PURSUANT  TO  SECTION  13  OR  15(d)  OF  THE SECURITIES  EXCHANGE  ACT  OF  1934
For the quarterly period ended September 30, 2013.

OR

[  ] TRANSITION REPORT  PURSUANT  TO  SECTION  13  OR  15(d)  OF  THE SECURITIES  EXCHANGE  ACT  OF  1934
For the transition period from                 to                .

Commission File Number   1-12273


ROPER INDUSTRIES, INC.
(Exact name of registrant as specified in its charter)

Delaware
(State or other jurisdiction of
incorporation or organization)
51-0263969
(I.R.S. Employer Identification No.)
6901 Professional Pkwy. East, Suite 200
Sarasota, Florida
(Address of principal executive offices)
 
34240
(Zip Code)
(941) 556-2601
(Registrant's telephone number, including area code)
     
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  þ Yes ¨  No

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).  þ Yes ¨  No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of "large accelerated filer," "accelerated filer" and "smaller reporting company" in Rule 12b-2 of the Exchange Act. (Check one):

þ Large accelerated filer
¨ Accelerated filer
¨ Non-accelerated filer
     (do not check if smaller reporting company)
¨ Smaller reporting company

Indicate by check mark if the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  ¨ Yes þ No

The number of shares outstanding of the Registrant's common stock as of November 1, 2013 was 99,309,540.


ROPER INDUSTRIES, INC.

REPORT ON FORM 10-Q FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2013

TABLE OF CONTENTS

 
 
   Page
PART I.
FINANCIAL INFORMATION
 
 
Item 1.
Financial Statements (unaudited):
 
 
 
Condensed Consolidated Statements of Earnings
 
3
 
Condensed Consolidated Statements of Comprehensive Income
 
4
 
Condensed Consolidated Balance Sheets
 
5
 
Condensed Consolidated Statements of Cash Flows
 
6
 
Condensed Consolidated Statement of Changes in Stockholders' Equity
 
7
 
Notes to Condensed Consolidated Financial Statements
 
8
Item 2.
Management's Discussion and Analysis of Financial Condition and Results of Operations
 
15
Item 3.
Quantitative and Qualitative Disclosures About Market Risk
 
22
Item 4.
Controls and Procedures
 
22
PART II.
OTHER INFORMATION
 
 
Item 1.
Legal Proceedings
 
23
Item 1A.
Risk Factors
 
23
Item 6.
Exhibits
 
23
 
Signatures
 
24


PART I. FINANCIAL INFORMATION

ITEM 1.                          FINANCIAL STATEMENTS


Roper Industries, Inc. and Subsidiaries
Condensed Consolidated Statements of Earnings (unaudited)
(in thousands, except per share data)

 
 
 
Three months ended September 30,
 
Nine months ended September 30,
 
 
 
2013
 
2012
 
2013
 
2012
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net sales
 
$
827,810
 
$
747,641
 
$
2,348,955
 
$
2,183,579
 
Cost of sales
 
 
345,185
 
 
331,086
 
 
999,247
 
 
978,223
 
Gross profit
 
 
482,625
 
 
416,555
 
 
1,349,708
 
 
1,205,356
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Selling, general and administrative expenses
 
 
263,276
 
 
233,298
 
 
765,436
 
 
673,011
 
Income from operations
 
 
219,349
 
 
183,257
 
 
584,272
 
 
532,345
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Interest expense
 
 
24,705
 
 
16,456
 
 
67,924
 
 
47,016
 
Loss on extinguishment of debt
 
 
-
 
 
1,043
 
 
-
 
 
1,043
 
Other income/(expense), net
 
 
409
 
 
(1,380
)
 
453
 
 
(2,444
)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Earnings before income taxes
 
 
195,053
 
 
164,378
 
 
516,801
 
 
481,842
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Income taxes
 
 
58,730
 
 
47,670
 
 
144,211
 
 
142,012
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net earnings
 
$
136,323
 
$
116,708
 
$
372,590
 
$
339,830
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net earnings per share:
 
 
 
 
 
 
 
 
 
 
 
 
 
Basic
 
$
1.37
 
$
1.19
 
$
3.76
 
$
3.49
 
Diluted
 
 
1.36
 
 
1.17
 
 
3.72
 
 
3.41
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Weighted average common shares outstanding:
 
 
 
 
 
 
 
 
 
 
 
 
 
Basic
 
 
99,207
 
 
97,876
 
 
99,058
 
 
97,460
 
Diluted
 
 
100,302
 
 
99,757
 
 
100,152
 
 
99,543
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dividends declared per common share
 
$
0.1650
 
$
0.1375
 
$
0.4950
 
$
0.4125
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 


See accompanying notes to condensed consolidated financial statements.



Roper Industries, Inc. and Subsidiaries
Condensed Consolidated Statements of Comprehensive Income (unaudited)
(in thousands)

 

 
 
Three months ended
September 30,
 
Nine months ended September 30,
 
 
 
2013
 
2012
 
2013
 
2012
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net earnings    
 
$
136,323
 
$
116,708
 
$
372,590
 
$
339,830
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Other comprehensive income/(loss), net of tax:
 
 
 
 
 
 
 
 
 
 
 
 
 
Foreign currency translation adjustments
 
 
31,902
 
 
36,395
 
 
(10,219
)
 
22,348
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Total other comprehensive income/(loss), net of tax
 
 
31,902
 
 
36,395
 
 
(10,219
)
 
22,348
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Comprehensive income
 
$
168,225
 
$
153,103
 
$
362,371
 
$
362,178
 


See accompanying notes to condensed consolidated financial statements.



Roper Industries, Inc. and Subsidiaries
Condensed Consolidated Balance Sheets (unaudited)
(in thousands)
 
 
 
September 30,
2013
 
December 31,
2012
 
ASSETS:    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
 
$
459,980
 
$
370,590
 
Accounts receivable, net 
 
 
505,284
 
 
526,408
 
Inventories, net
 
 
204,722
 
 
190,867
 
Deferred taxes    
 
 
88,421
 
 
41,992
 
Unbilled receivables
 
 
85,375
 
 
72,193
 
Other current assets
 
 
45,417
 
 
43,492
 
Total current assets
 
 
1,389,199
 
 
1,245,542
 
 
 
 
 
 
 
 
 
Property, plant and equipment, net
 
 
117,785
 
 
110,397
 
Goodwill
 
 
4,541,772
 
 
3,868,857
 
Other intangible assets, net 
 
 
2,051,685
 
 
1,698,867
 
Deferred taxes
 
 
68,048
 
 
78,644
 
Other assets
 
 
77,086
 
 
68,797
 
 
 
 
 
 
 
 
 
Total assets
 
$
8,245,575
 
$
7,071,104
 
 
 
 
 
 
 
 
 
LIABILITIES AND STOCKHOLDERS' EQUITY:    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Accounts payable
 
$
142,987
 
$
138,340
 
Accrued compensation
 
 
100,901
 
 
110,724
 
Deferred revenue
 
 
212,275
 
 
185,912
 
Other accrued liabilities
 
 
153,293
 
 
128,351
 
Deferred taxes
 
 
12,431
 
 
3,868
 
Current portion of long-term debt, net
 
 
12,250
 
 
519,015
 
Total current liabilities
 
 
634,137
 
 
1,086,210
 
 
 
 
 
 
 
 
 
Long-term debt, net of current portion
 
 
2,593,607
 
 
1,503,107
 
Deferred taxes
 
 
862,986
 
 
707,278
 
Other liabilities
 
 
92,032
 
 
86,783
 
Total liabilities
 
 
4,182,762
 
 
3,383,378
 
 
 
 
 
 
 
 
 
Commitments and contingencies (Note 10)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Common stock
 
 
1,013
 
 
1,006
 
Additional paid-in capital
 
 
1,219,648
 
 
1,158,001
 
Retained earnings
 
 
2,813,356
 
 
2,489,858
 
Accumulated other comprehensive earnings
 
 
48,318
 
 
58,537
 
Treasury stock
 
 
(19,522
)
 
(19,676
)
Total stockholders' equity
 
 
4,062,813
 
 
3,687,726
 
 
 
 
 
 
 
 
 
Total liabilities and stockholders' equity
 
$
8,245,575
 
$
7,071,104
 


See accompanying notes to condensed consolidated financial statements.


Roper Industries, Inc. and Subsidiaries
Condensed Consolidated Statements of Cash Flows (unaudited)
(in thousands)


 
 
 
Nine months ended September 30,
 
 
 
2013
 
2012
 
Cash flows from operating activities:
 
 
 
 
 
 
 
Net earnings
 
$
372,590
 
$
339,830
 
Adjustments to reconcile net earnings to cash flows from operating activities:
 
 
 
 
 
 
 
Depreciation and amortization of property, plant and equipment
 
 
28,269
 
 
28,402
 
Amortization of intangible assets
 
 
111,210
 
 
82,398
 
Amortization of deferred financing costs
 
 
2,916
 
 
1,750
 
Non-cash stock compensation
 
 
40,040
 
 
30,143
 
Changes in operating assets and liabilities, net of acquired businesses:
 
 
 
 
 
 
 
Accounts receivable
 
 
43,101
 
 
6,685
 
Unbilled receivables
 
 
(13,257
)
 
(2,698
)
Inventories
 
 
(15,202
)
 
(2,985
)
Accounts payable and accrued liabilities
 
 
13,055
 
 
(8,617
)
Income taxes
 
 
(12,643
)
 
(14,258
)
Other, net
 
 
(3,306
)
 
5,564
 
Cash provided by operating activities
 
 
566,773
 
 
466,214
 
 
 
 
 
 
 
 
 
Cash flows from investing activities:
 
 
 
 
 
 
 
Acquisitions of businesses, net of cash acquired
 
 
(1,014,952
)
 
(1,445,549
)
Capital expenditures
 
 
(33,349
)
 
(29,236
)
Proceeds from sale of assets
 
 
1,740
 
 
1,196
 
Other, net
 
 
(144
)
 
(542
)
Cash used in investing activities
 
 
(1,046,705
)
 
(1,474,131
)
 
 
 
 
 
 
 
 
Cash flows from financing activities:
 
 
 
 
 
 
 
Proceeds from senior notes
 
 
800,000
 
 
-
 
Payment of senior notes
 
 
(500,000
)
 
-
 
Borrowings/(payments) under revolving line of credit, net
 
 
290,000
 
 
1,050,000
 
Principal payments on convertible notes
 
 
(2,115
)
 
(26,826
)
Cash premiums paid on convertible note conversions
 
 
(5,100
)
 
(19,149
)
Debt issuance costs
 
 
(7,717
)
 
(4,551
)
Cash dividends to stockholders
 
 
(32,706
)
 
(40,102
)
Proceeds from stock based compensation, net
 
 
16,839
 
 
40,105
 
Stock award tax excess windfall benefit
 
 
7,763
 
 
19,873
 
Treasury stock sales
 
 
1,833
 
 
1,623
 
Other
 
 
723
 
 
(979
)
Cash provided by financing activities
 
 
569,520
 
 
1,019,994
 
 
 
 
 
 
 
 
 
Effect of foreign currency exchange rate changes on cash
 
 
(198
)
 
4,931
 
 
 
 
 
 
 
 
 
Net increase in cash and cash equivalents
 
 
89,390
 
 
17,008
 
 
 
 
 
 
 
 
 
Cash and cash equivalents, beginning of period
 
 
370,590
 
 
338,101
 
 
 
 
 
 
 
 
 
Cash and cash equivalents, end of period
 
$
459,980
 
$
355,109
 


See accompanying notes to condensed consolidated financial statements.



Roper Industries, Inc. and Subsidiaries
Condensed Consolidated Statements of Changes in Stockholders' Equity (unaudited)
(in thousands)


 
 
Common
stock
 
Additional paid-in capital
 
Retained
earnings
 
Accumulated other comprehensive earnings
 
Treasury
stock
 
Total
 
Balances at December 31, 2012
 
$
1,006
 
$
1,158,001
 
$
2,489,858
 
$
58,537
 
$
(19,676
)
$
3,687,726
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net earnings    
 
 
-
 
 
-
 
 
372,590
 
 
-
 
 
-
 
 
372,590
 
Stock option exercises    
 
 
4
 
 
20,446
 
 
-
 
 
-
 
 
-
 
 
20,450
 
Treasury stock sold
 
 
-
 
 
1,679
 
 
-
 
 
-
 
 
154
 
 
1,833
 
Currency translation adjustments, net of $889 tax
 
 
-
 
 
-
 
 
-
 
 
(10,219
)
 
-
 
 
(10,219
)
Stock based compensation 
 
 
-
 
 
40,201
 
 
-
 
 
-
 
 
-
 
 
40,201
 
Restricted stock activity 
 
 
3
 
 
(3,598
)
 
-
 
 
-
 
 
-
 
 
(3,595
)
Stock option tax benefit, net of shortfalls
 
 
-
 
 
7,632
 
 
-
 
 
-
 
 
-
 
 
7,632
 
Conversion of senior subordinated convertible notes,
net of $386 tax
 
 
 
 
 
(4,713
)
 
-
 
 
-
 
 
-
 
 
(4,713
)
Dividends declared
 
 
-
 
 
-
 
 
(49,092
)
 
-
 
 
-
 
 
(49,092
)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Balances at September 30, 2013
 
$
1,013
 
$
1,219,648
 
$
2,813,356
 
$
48,318
 
$
(19,522
)
$
4,062,813
 


See accompanying notes to condensed consolidated financial statements.


Roper Industries, Inc. and Subsidiaries
Notes to Condensed Consolidated Financial Statements (unaudited)
September 30, 2013


1.
Basis of Presentation

The accompanying condensed consolidated financial statements for the three and nine month periods ended September 30, 2013 and 2012 are unaudited. In the opinion of management, the accompanying unaudited condensed consolidated financial statements reflect all adjustments, which include only normal recurring adjustments, necessary to state fairly the financial position, results of operations, comprehensive income and cash flows of Roper Industries, Inc. and its subsidiaries ("Roper" or the "Company") for all periods presented. The December 31, 2012 financial position data included herein was derived from the audited consolidated financial statements included in the 2012 Annual Report on Form 10-K ("Annual Report") filed on February 25, 2013 with the Securities and Exchange Commission ("SEC") but does not include all disclosures required by U.S. generally accepted accounting principles ("GAAP").

Roper's management has made a number of estimates and assumptions relating to the reporting of assets and liabilities and the disclosure of contingent assets and liabilities to prepare these condensed consolidated financial statements in conformity with GAAP. Actual results could differ from those estimates.

The results of operations for the three and nine month periods ended September 30, 2013 are not necessarily indicative of the results to be expected for the full year. You should read these unaudited condensed consolidated financial statements in conjunction with Roper's consolidated financial statements and the notes thereto included in its Annual Report.


2.
Recent Accounting Pronouncements

The Financial Accounting Standards Board ("FASB") establishes changes to accounting principles under GAAP in the form of accounting standards updates ("ASUs") to the FASB's Accounting Standards Codification.  The Company considers the applicability and impact of all ASUs.  Any ASUs not listed below were assessed and determined to be either not applicable or are expected to have an immaterial impact on the Company's results of operations, financial position or cash flows.

In July 2012, the FASB issued an amendment to accounting rules related to the testing of indefinite-lived intangibles.  The new accounting rules permit an entity to first assess qualitative factors to determine if it is more likely than not that an indefinite-lived asset is impaired as a basis for determining whether it is necessary to perform the quantitative impairment test prescribed under current accounting rules.   Roper adopted this guidance on January 1, 2013.  The guidance did not have an impact on the Company's results of operations, financial position or cash flows.


3.
Earnings Per Share

Basic earnings per share were calculated using net earnings and the weighted average number of shares of common stock outstanding during the respective period. Diluted earnings per share were calculated using net earnings and the weighted average number of shares of common stock and potential common stock outstanding during the respective period. Potentially dilutive common stock consisted of stock options and the premium over the conversion price on Roper's senior subordinated convertible notes based upon the trading price of Roper's common stock. The effects of potential common stock were determined using the treasury stock method.  Weighted average shares outstanding are as shown below (in thousands):

 
 
Three months ended September 30,
   
Nine months ended September 30,
 
 
 
2013
   
2012
   
2013
   
2012
 
Basic shares outstanding
   
99,207
     
97,876
     
99,058
     
97,460
 
Effect of potential common stock:
                               
Common stock awards
   
905
     
1,017
     
894
     
1,077
 
Senior subordinated convertible notes
   
190
     
864
     
200
     
1,006
 
Diluted shares outstanding
   
100,302
     
99,757
     
100,152
     
99,543
 

For the three and nine month periods ended September 30, 2013 there were 551,850 and 601,350 outstanding stock options, respectively, that were not included in the determination of diluted earnings per share because doing so would have been antidilutive; this compares to 540,266 and 589,666 outstanding stock options, respectively, that would have been antidilutive for the three and nine month periods ended September 30, 2012.


4.
Business Acquisitions

On May 1, 2013, Roper acquired 100% of the shares of Managed Health Care Associates, Inc. ("MHA"), in a $1.0 billion all-cash transaction.  MHA is a leading provider of services and technologies to support the diverse and complex needs of alternate site health care providers who deliver services outside of an acute care hospital setting. The acquisition of MHA complements and expands the Company's medical platform.  MHA is reported in the Medical & Scientific Imaging segment.

During the nine month period ended September 30, 2013, the Company expensed transaction costs of $2.5 million related to the acquisition as corporate general and administrative expenses, as incurred.

The following table (in thousands) summarizes the fair values of the assets acquired and liabilities assumed at the date of acquisition.  The allocation of the purchase price is considered preliminary pending tax-related adjustments.  Pro forma data has not been provided as the acquisition of MHA was not material to the Company's operations.

Current assets
$         59,813
 
Identifiable intangibles
465,500
 
Goodwill
680,732
 
Other assets
5,798
 
Total assets acquired
1,211,843
 
Current liabilities
(24,717
)
Long-term deferred tax liability
(165,052
)
Other liabilities
(6,524
)
Net assets acquired
$    1,015,550
 

The fair value of current assets acquired also includes an adjustment of $35.0 million for administrative fees related to customer purchases that occurred prior to the acquisition date but not reported to MHA until after the acquisition date. In the ordinary course, these administrative fees are recorded as revenue when reported; however, GAAP accounting for business acquisitions requires the Company to estimate the amount of purchases occurring prior to the acquisition date and record the fair value of the administrative fees to be received from those purchases as an accounts receivable at the date of acquisition. The Company also recorded a fair value liability of $8.6 million included in current liabilities related to corresponding revenue-share obligation owed to customers that generated the administrative fees.  Both of these fair value adjustments were fully amortized as of September 30, 2013.

The majority of the goodwill is not expected to be deductible for tax purposes.  Of the $466 million of intangible assets acquired, $28 million was assigned to trade names that are not subject to amortization. The remaining $438 million of acquired intangible assets have a weighted-average useful life of approximately 20 years. The intangible assets that make up that amount include customer relationships of $433 million (20 year weighted-average useful life) and technology of $5 million (3 year weighted-average useful life).

On August 22, 2012, Roper acquired 100% of the shares of Sunquest Information Systems, Inc. ("Sunquest").  Roper's results for the quarter ended September 30, 2012 included results from Sunquest between August 22, 2012 and September 30, 2012.  In that period, Sunquest contributed $21.0 million in revenue and $0.2 million of earnings (inclusive of deal-related costs) to Roper's results.  The following unaudited pro forma summary presents consolidated information as if the acquisition of Sunquest had occurred on January 1, 2011.  This supplemental pro forma information does not purport to be indicative of what would have occurred had the acquisition of Sunquest been completed on January 1, 2011, nor is it indicative of any future results. Amounts shown are in thousands, except per share data:

 
 
Three months ended
September 30, 2012
   
Nine months ended
September 30, 2012
 
Sales
 
$
780,278
   
$
2,320,497
 
Net income
   
128,226
     
380,046
 
Earnings per share, basic
   
1.31
     
3.90
 
Earnings per share, diluted
   
1.29
     
3.82
 

Pro forma earnings for the three and nine months ended September 30, 2012 were adjusted by $41.3 million and $50.6 million, respectively, for non-recurring acquisition and other costs as well as recurring changes in amortization, interest expense and taxes related to the acquisition.


5.
Stock Based Compensation

The Roper Industries, Inc. Amended and Restated 2006 Incentive Plan (the "Plan") is a stock based compensation plan used to grant incentive stock options, nonqualified stock options, restricted stock, stock appreciation rights or equivalent instruments to Roper's employees, officers and directors.

Roper's stock purchase plan allows employees in the U.S. and Canada to designate up to 10% of eligible earnings to purchase Roper's common stock at a 5% discount to the average closing price of the stock at the beginning and end of a quarterly offering period. The common stock sold to the employees may be either treasury stock, stock purchased on the open market, or newly issued shares.

The following table provides information regarding the Company's stock based compensation expense (in thousands):

 
 
Three months ended September 30,
   
Nine months ended
September 30,
 
 
 
2013
   
2012
   
2013
   
2012
 
Stock based compensation
 
$
13,756
   
$
10,439
   
$
40,040
   
$
30,143
 
Tax effect recognized in net income
   
4,814
     
3,654
     
14,014
     
10,550
 
Windfall tax benefit, net
   
2,075
     
9,009
     
7,632
     
19,975
 

Stock Options - In the nine month period ended September 30, 2013, 560,350 options were granted with a weighted average fair value of $36.87 per option. During the same period in 2012, 531,100 options were granted with a weighted average fair value of $30.19 per option. All options were issued at grant date fair value, which is defined by the Plan as the closing price of Roper's common stock on the date of grant.

Roper records compensation expense for employee stock options based on the estimated fair value of the options on the date of grant using the Black-Scholes option-pricing model. Historical data, among other factors, is used to estimate the expected price volatility, the expected dividend yield, the expected option life and the expected forfeiture rate. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant for the estimated life of the option. The following weighted average assumptions were used to estimate the fair value of options granted during the current and prior year periods using the Black-Scholes option-pricing model:

 
Nine months ended September 30,
 
2013
 
2012
Fair value per share ($)
36.87
 
30.19
Risk-free interest rate (%)
0.80
 
0.77
Expected option life (years)
5.19
 
5.24
Expected volatility (%)
36.20
 
36.51
Expected dividend yield (%)
0.57
 
0.58

Cash received from option exercises for the nine months ended September 30, 2013 and 2012 was $20.5 million and $40.1 million, respectively.

Restricted Stock Awards - During the nine months ended September 30, 2013, 357,240 restricted stock awards were granted with a weighted average fair value of $116.76 per restricted share. During the same period in 2012, 358,807 awards were granted with a weighted average fair value of $95.10 per restricted share. All grants were issued at grant date fair value.

During the nine months ended September 30, 2013, 123,762 restricted awards vested with a weighted average grant date fair value of $63.65 per restricted share, at a weighted average vest date fair value of $120.92 per restricted share.

Employee Stock Purchase Plan - During the nine month periods ended September 30, 2013 and 2012, participants of the employee stock purchase plan purchased 15,458 and 17,410 shares, respectively, of Roper's common stock for total consideration of $1.8 million and $1.6 million, respectively. All shares were purchased from Roper's treasury shares.


6.
Inventories

The components of inventories at September 30, 2013 and December 31, 2012 were as follows (in thousands)

 
 
September 30,
2013
 
December 31,
2012
 
Raw materials and supplies
 
$
128,809
 
$
121,573
 
Work in process
 
 
33,133
 
 
29,725
 
Finished products
 
 
88,614
 
 
81,536
 
Inventory reserves
 
 
(45,834
)
 
(41,967
)
 
 
$
204,722
 
$
190,867
 


7.
Goodwill and Other Intangible Assets

The carrying value of goodwill by segment is as follows (in thousands):

 
 
Industrial Technology
 
Energy Systems & Controls
 
Medical & Scientific 
Imaging
 
RF
Technology
 
Total
 
Balances at December 31, 2012
 
$
421,755
 
$
404,057
 
$
1,772,402
 
$
1,270,643
 
$
3,868,857
 
Additions
 
 
-
 
 
-
 
 
680,732
 
 
-
 
 
680,732
 
Other
 
 
-
 
 
2,660
 
 
(4,283
)
 
445
 
 
(1,178
)
Currency translation adjustments
 
 
1,929
 
 
(215
)
 
(7,084
)
 
(1,269
)
 
(6,639
)
Balances at September 30, 2013
 
$
423,684
 
$
406,502
 
$
2,441,767
 
$
1,269,819
 
$
4,541,772
 


 

Other intangible assets are comprised of (in thousands):

 
 
Cost
 
Accumulated
amortization
 
Net book
value
 
Assets subject to amortization:
 
 
 
 
 
 
 
 
 
 
Customer related intangibles
 
$
1,509,339
 
$
(379,535
)
$
1,129,804
 
Unpatented technology
 
 
198,609
 
 
(97,487
)
 
101,122
 
Software
 
 
160,520
 
 
(44,256
)
 
116,264
 
Patents and other protective rights
 
 
40,399
 
 
(20,312
)
 
20,087
 
Trade secrets
 
 
1,500
 
 
(1,500
)
 
-
 
Assets not subject to amortization:
 
 
 
 
 
 
 
 
 
 
Trade names
 
 
331,590
 
 
-
 
 
331,590
 
Balances at December 31, 2012
 
$
2,241,957
 
$
(543,090
)
$
1,698,867
 
 
 
 
 
 
 
 
 
 
 
 
Assets subject to amortization:
 
 
 
 
 
 
 
 
 
 
Customer related intangibles
 
$
1,939,270
 
$
(456,068
)
$
1,483,202
 
Unpatented technology
 
 
212,049
 
 
(116,355
)
 
95,694
 
Software
 
 
160,496
 
 
(54,777
)
 
105,719
 
Patents and other protective rights
 
 
30,390
 
 
(22,017
)
 
8,373
 
Trade secrets
 
 
1,500
 
 
(1,500
)
 
-
 
Assets not subject to amortization:
 
 
 
 
 
 
 
 
 
 
Trade names
 
 
358,697
 
 
-
 
 
358,697
 
Balances at September 30, 2013
 
$
2,702,402
 
$
(650,717
)
$
2,051,685
 

Amortization expense of other intangible assets was $108,223 and $79,335 during the nine months ended September 30, 2013 and 2012, respectively.


8.
Debt

On June 6, 2013, the Company completed a public offering of $800 million aggregate principal amount of 2.05% senior unsecured notes due October 1, 2018.  The notes were issued at 99.791% of their principal amount.  The net proceeds were used to pay a portion of the outstanding revolver balance under Roper's revolving credit facility.

The notes bear interest at a fixed rate of 2.05% per year, payable semi-annually in arrears on April 1 and October 1 of each year, beginning October 1, 2013.

Roper may redeem some or all of these notes at any time or from time to time, at 100% of their principal amount, plus a make-whole premium based on a spread to U.S. Treasury securities.

The notes are unsecured senior obligations of the Company and rank equally in right of payment with all of its existing and future unsecured and unsubordinated indebtedness.  The notes are effectively subordinated to any existing and future secured indebtedness to the extent of the value of the collateral securing such indebtedness.  The notes are not guaranteed by any of Roper's subsidiaries and are effectively subordinated to all existing and future indebtedness and other liabilities of its subsidiaries.

On August 15, 2013, $500 million of senior notes matured, and were repaid using borrowings from the Company's $1.5 billion revolving credit facility.

Roper's 3.75% senior subordinated convertible notes due 2034 became convertible on January 15, 2009.  During the nine month period ended September 30, 2013, 4,471 notes were converted for $7.1 million in cash.  No gain or loss was recorded upon these conversions.  In addition, a related $0.4 million deferred tax liability associated with excess deductions recorded for tax purposes was relieved to additional paid-in capital upon the conversions.

At September 30, 2013, the conversion price on the outstanding notes was $470.55.  If converted at September 30, 2013, the value would exceed the $10 million principal amount of the notes by approximately $25 million and could result in the issuance of 190,306 shares of Roper's common stock.


9.
Fair Value of Financial Instruments

Roper's debt at September 30, 2013 included $2.2 billion of fixed-rate senior notes with the following fair values (in millions):

$400 million senior notes due 2017
$  398
$800 million senior notes due 2018
786
$500 million senior notes due 2019
583
$500 million senior notes due 2022
468

The fair values of the senior notes are based on the trading prices of the notes, which the Company has determined to be Level 2 in the FASB fair value hierarchy.  Short-term debt included $10 million of fixed-rate convertible notes which were at fair value due to the ability of note holders to exercise the conversion option of the notes.

On August 15, 2013, an aggregate notional amount of $500 million in interest rate swaps expired.  The swaps had been designated as fair value hedges which had effectively changed Roper's $500 million senior notes due 2013 with a fixed interest rate of 6.625% to a variable-rate obligation at a weighted average spread of 4.377% plus the 3 month London Interbank Offered Rate ("LIBOR").


10.
Contingencies

Roper, in the ordinary course of business, is the subject of, or a party to, various pending or threatened legal actions, including product liability and employment practices. The Company is vigorously contesting all lawsuits that, in general, are based upon claims of the kind that have been customary over the past several years. After analyzing the Company's contingent liabilities on a gross basis and, based upon past experience with resolution of its product liability and employment practices claims and the limits of the primary, excess, and umbrella liability insurance coverages that are available with respect to pending claims, management believes that adequate provision has been made to cover any potential liability not covered by insurance, and that the ultimate liability, if any, arising from these actions should not have a material adverse effect on Roper's consolidated financial position, results of operations or cash flows.

Over recent years there has been an increase in certain U.S. states in asbestos-related litigation claims against numerous industrial companies. Roper or its subsidiaries have been named defendants in some such cases. No significant resources have been required by Roper to respond to these cases and the Company believes it has valid defenses to such claims and, if required, intends to defend them vigorously. Given the state of these claims it is not possible to determine the potential liability, if any.

Roper's financial statements include accruals for potential product liability and warranty claims based on its claims experience. Such costs are accrued at the time revenue is recognized. A summary of the warranty accrual activity for the nine months ended September 30, 2013 is presented below (in thousands):

Balance at December 31, 2012
 
$
9,755
 
Additions charged to costs and expenses*
 
 
17,659
 
Deductions
 
 
(11,251
)
Other
 
 
(168)
 
Balance at September 30, 2013
 
$
15,995
 

* During the second quarter of 2013, the Company identified a vendor-supplied component within a refrigeration system valve that did not meet its quality standards, and $9.1 million was expensed to cover the estimated cost of replacing the faulty components for customers.


11.
Business Segments

Sales and operating profit by industry segment are set forth in the following table (dollars in thousands):
 
 
Three months ended
September 30,
 
 
Nine months ended
September 30,
 
 
 
2013
 
2012
Change
 
2013
 
2012
Change
 
Net sales:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Industrial Technology
$
200,684
 
$
199,008
0.8
%
$
580,466
 
$
598,088
(2.9
)%
Energy Systems & Controls
 
155,058
 
 
158,169
(2.0
)
 
456,031
 
 
461,508
(1.2
)
Medical & Scientific Imaging
 
237,338
 
 
172,475
37.6
 
 
645,739
 
 
486,207
32.8
 
RF Technology
 
234,730
 
 
217,989
7.7
 
 
666,719
 
 
637,776
4.5
 
Total
$
827,810
 
$
747,641
10.7
%
$
2,348,955
 
$
2,183,579
7.6
%
Gross profit:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Industrial Technology
$
101,259
 
$
102,569
(1.3
)%
$
296,414
 
$
304,002
(2.5
)%
Energy Systems & Controls
 
88,104
 
 
87,782
0.4
 
 
256,431
 
 
254,325
0.8
 
Medical & Scientific Imaging
 
167,433
 
 
112,013
49.5
 
 
440,718
 
 
314,411
40.2
 
RF Technology
 
125,829
 
 
114,191
10.2
 
 
356,145
 
 
332,618
7.1
 
Total
$
482,625
 
$
416,555
15.9
%
$
1,349,708
 
$
1,205,356
12.0
%
Operating profit*:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Industrial Technology
$
60,753
 
$
60,628
0.2
%
$
164,278
 
$
180,211
(8.8
)%
Energy Systems & Controls
 
41,076
 
 
42,890
(4.2
)
 
118,432
 
 
118,749
(0.3
)
Medical & Scientific Imaging
 
71,968
 
 
46,190
55.8
 
 
179,433
 
 
125,231
43.3
 
RF Technology
 
66,469
 
 
58,002
14.6
 
 
183,828
 
 
166,516
10.4
 
Total
$
240,266
 
$
207,710
15.7
%
$
645,971
 
$
590,707
9.4
%
Long-lived assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Industrial Technology
$
49,055
 
$
42,970
 
 
 
 
 
 
 
 
 
Energy Systems & Controls
 
19,501
 
 
19,016
 
 
 
 
 
 
 
 
 
Medical & Scientific Imaging
 
43,105
 
 
44,784
 
 
 
 
 
 
 
 
 
RF Technology
 
28,360
 
 
29,230
 
 
 
 
 
 
 
 
 
Total
$
140,021
 
$
136,000
 
 
 
 
 
 
 
 
 

*Segment operating profit is before unallocated corporate general and administrative expenses. These expenses were $20,917 and $24,453 for the three months ended September 30, 2013 and 2012, respectively, and $61,699 and $58,362 for the nine months ended September 30, 2013 and 2012, respectively.


ITEM 2.                                        MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
 

You should read the following discussion in conjunction with Management's Discussion and Analysis of Financial Conditions and Results of Operations included in our Annual Report for the year ended December 31, 2012 as filed on February 25, 2013 with the Securities and Exchange Commission ("SEC") and the notes to our Condensed Consolidated Financial Statements included elsewhere in this report.

Information About Forward-Looking Statements

This report includes "forward-looking statements" within the meaning of the federal securities laws. In addition, we, or our executive officers on our behalf, may from time to time make forward-looking statements in reports and other documents we file with the SEC or in connection with oral statements made to the press, potential investors or others. All statements that are not historical facts are "forward-looking statements."  Forward-looking statements may be indicated by words or phrases such as "anticipate," "estimate," "plans," "expects," "projects," "should," "will," "believes" or "intends" and similar words and phrases. These statements reflect management's current beliefs and are not guarantees of future performance. They involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied in any forward-looking statement.

Examples of forward-looking statements in this report include but are not limited to statements regarding operating results, the success of our internal operating plans, our expectations regarding our ability to generate operating cash flows and reduce debt and associated interest expense, profit and cash flow expectations, the prospects for newly acquired businesses to be integrated and contribute to future growth and our expectations regarding growth through acquisitions. Important assumptions relating to the forward-looking statements include, among others, assumptions regarding demand for our products, the cost, timing and success of product upgrades and new product introductions, raw materials costs, expected pricing levels, the timing and cost of expected capital expenditures, expected outcomes of pending litigation, competitive conditions, general economic conditions and expected synergies relating to acquisitions, joint ventures and alliances. These assumptions could prove inaccurate. Although we believe that the estimates and projections reflected in the forward-looking statements are reasonable, our expectations may prove to be incorrect. Important factors that could cause actual results to differ materially from estimates or projections contained in the forward-looking statements include, but are not limited to:

·
general economic conditions;
·
difficulty making acquisitions and successfully integrating acquired businesses;
·
any unforeseen liabilities associated with future acquisitions;
·
limitations on our business imposed by our indebtedness;
·
unfavorable changes in foreign exchange rates;
·
difficulties associated with exports;
·
risks and costs associated with our international sales and operations;
·
increased directors' and officers' liability and other insurance costs;
·
risk of rising interest rates;
·
product liability and insurance risks;
·
increased warranty exposure;
·
future competition;
·
the cyclical nature of some of our markets;
·
reduction of business with large customers;
·
risks associated with government contracts;
·
changes in the supply of, or price for, raw materials, parts and components;
·
environmental compliance costs and liabilities;
·
risks and costs associated with asbestos-related litigation;
·
potential write-offs of our substantial goodwill and other intangible assets;
·
our ability to successfully develop new products;
·
failure to protect our intellectual property;
·
the effect of, or change in, government regulations (including tax);
·
economic disruption caused by terrorist attacks, health crises or other unforeseen events; and
·
the factors discussed in other reports filed with the SEC.
We believe these forward-looking statements are reasonable; however, you should not place undue reliance on any forward-looking statements, which are based on current expectations. Further, forward-looking statements speak only as of the date they are made, and we undertake no obligation to publicly update any of these statements in light of new information or future events.


Overview

Roper Industries, Inc. ("Roper," "we" or "us") is a diversified growth company that designs, manufactures and distributes radio frequency ("RF") products, services and application software, industrial technology products, energy systems and controls and medical and scientific imaging products and software. We market these products and services to a broad range of markets, including RF applications, medical, water, energy, research, education, software-as-a-service ("SaaS")-based information networks, security and other niche markets.

We pursue consistent and sustainable growth in earnings by emphasizing continuous improvement in the operating performance of our existing businesses and by acquiring other carefully selected businesses that offer high value-added services, engineered products and solutions and are capable of achieving growth and maintaining high margins. Our acquisitions have represented both financial bolt-ons and new strategic platforms. We strive for high cash and earnings returns from our investments.


Critical Accounting Policies

There were no material changes during the three or nine month periods ended September 30, 2013 to the items that we disclosed as our critical accounting policies and estimates in "Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations" in our 2012 Annual Report on Form 10-K filed on February 25, 2013.


Recently Issued Accounting Standards

Information regarding new accounting pronouncements is included in Note 2 of the notes to Condensed Consolidated Financial Statements.
 
 
Results of Operations

General

The following tables set forth selected information for the periods indicated. Dollar amounts are in thousands and percentages are the particular line item shown as a percentage of net sales. Percentages may not foot due to rounding.

 
 
 
Three months ended
September 30,
 
Nine months ended
September 30,
 
 
 
2013
 
2012
 
2013
 
2012
 
Net sales:
 
 
 
 
 
 
 
 
 
 
 
 
 
Industrial Technology
 
$
200,684
 
$
199,008
 
$
580,466
 
$
598,088
 
Energy Systems & Controls
 
 
155,058
 
 
158,169
 
 
456,031
 
 
461,508
 
Medical & Scientific Imaging
 
 
237,338
 
 
172,475
 
 
645,739
 
 
486,207
 
RF Technology
 
 
234,730
 
 
217,989
 
 
666,719
 
 
637,776
 
Total
 
$
827,810
 
$
747,641
 
$
2,348,955
 
$
2,183,579
 
Gross profit:
 
 
 
 
 
 
 
 
 
 
 
 
 
Industrial Technology
 
 
50.5
%
 
51.5
%
 
51.1
%
 
50.8
%
Energy Systems & Controls
 
 
56.8
 
 
55.5
 
 
56.2
 
 
55.1
 
Medical & Scientific Imaging
 
 
70.5
 
 
64.9
 
 
68.3
 
 
64.7
 
RF Technology
 
 
53.6
 
 
52.4
 
 
53.4
 
 
52.2
 
Total
 
 
58.3
 
 
55.7
 
 
57.5
 
 
55.2
 
Selling, general & administrative expenses:
 
 
 
 
 
 
 
 
 
 
 
 
 
Industrial Technology
 
 
20.2
%
 
21.1
%
 
22.8
%
 
20.7
%
Energy Systems & Controls
 
 
30.3
 
 
28.4
 
 
30.3
 
 
29.4
 
Medical & Scientific Imaging
 
 
40.2
 
 
38.2
 
 
40.5
 
 
38.9
 
RF Technology
 
 
25.3
 
 
25.8
 
 
25.8
 
 
26.0
 
Total
 
 
29.3
 
 
27.9
 
 
30.0
 
 
28.1
 
Segment operating profit:
 
 
 
 
 
 
 
 
 
 
 
 
 
Industrial Technology
 
 
30.3
%
 
30.5
%
 
28.3
%
 
30.1
%
Energy Systems & Controls
 
 
26.5
 
 
27.1
 
 
26.0
 
 
25.7
 
Medical & Scientific Imaging
 
 
30.3
 
 
26.8
 
 
27.8
 
 
25.8
 
RF Technology
 
 
28.3
 
 
26.6
 
 
27.6
 
 
26.1
 
Total
 
 
29.0
 
 
27.8
 
 
27.5
 
 
27.1
 
Corporate administrative expenses
 
 
(2.5
)
 
(3.3
)
 
(2.6
)
 
(2.7
)
 
 
 
26.5
 
 
24.5
 
 
24.9
 
 
24.4
 
Interest expense
 
 
(3.0
)
 
(2.2
)
 
(2.9
)
 
(2.2
)
Other income/(expense)
 
 
-
 
 
(0.3
)
 
-
 
 
(0.2
)
Earnings before income taxes
 
 
23.6
 
 
22.0
 
 
22.0
 
 
22.1
 
Income taxes
 
 
(7.1
)
 
(6.4
)
 
(6.1
)
 
(6.5
)
Net earnings
 
 
16.5
%
 
15.6
%
 
15.9
%
 
15.6
%




Three months ended September 30, 2013 compared to three months ended September 30, 2012

Net sales for the quarter ended September 30, 2013 were $827.8 million as compared to $747.6 million in the prior year quarter, an increase of 11%. The increase was the result of organic growth of 3% and an 8% increase in sales from acquisitions.

In our Industrial Technology segment, net sales were up 1% to $200.7 million in the third quarter of 2013 as compared to $199.0 million in the third quarter of 2012 due to increased sales in our fluid handling businesses.  Gross margins decreased to 50.5% in the third quarter of 2013 as compared to 51.5% in the third quarter of 2012 due to product mix. Selling, general and administrative ("SG&A") expenses as a percentage of net sales were 20.2% in the third quarter of 2013, compared to 21.1% in the prior year quarter due to product mix. The resulting operating profit margins were 30.3% in the third quarter of 2013 as compared to 30.5% in the third quarter of 2012.

Net sales in our Energy Systems & Controls segment decreased by 2% to $155.1 million during the third quarter of 2013 compared to $158.2 million in the third quarter of 2012, due to decreased demand in nuclear plant inspection end markets offset in part by increased demand for control systems for oil and gas applications.  Gross margins increased to 56.8% in the third quarter of 2013 compared to 55.5% in the third quarter of 2012 due to product mix. SG&A expenses as a percentage of net sales were 30.3% in the third quarter of 2013, compared to 28.4% in the prior year quarter due to negative operating leverage on lower sales volume. As a result, operating margins were 26.5% in the third quarter of 2013 as compared to 27.1% in the third quarter of 2012.

In our Medical & Scientific Imaging segment, net sales increased by 38% to $237.3 million in the third quarter of 2013 as compared to $172.5 million in the third quarter of 2012. The change was comprised of a 35% increase from acquisitions, organic growth of 3%, and a small negative impact from foreign exchange.  We experienced continued growth in our medical businesses, offset in part by weakness in camera sales into research markets.  Gross margins increased to 70.5% in the third quarter of 2013 from 64.9% in the third quarter of 2012 due to the higher gross margin profile of our acquired businesses. SG&A expenses as a percentage of net sales increased to 40.2% in the third quarter of 2013 as compared to 38.2% in the third quarter of 2012 due to SG&A expenses at MHA in which the corresponding revenues were not recognizable under GAAP (see Note 4 of the notes to Condensed Consolidated Financial Statements). As a result, operating margins were 30.3% in the third quarter of 2013 as compared to 26.8% in the third quarter of 2012.

In our RF Technology segment, net sales were $234.7 million in the third quarter of 2013 as compared to $218.0 million in the third quarter of 2012, an increase of 8%.  The increase was due primarily to growth in our toll and traffic and university card systems businesses. Gross margins increased to 53.6% in the third quarter of 2013, as compared to 52.4% in the prior year quarter due to a more favorable mix between products and software in the current year quarter. SG&A expenses as a percentage of net sales in the third quarter of 2013 were 25.3% as compared to 25.8% in the prior year. As a result, operating profit margins were 28.3% in the third quarter of 2013 as compared to 26.6% in the third quarter of 2012.

Corporate expenses were $20.9 million, or 2.5% of net sales, in the third quarter of 2013 as compared to $24.5 million, or 3.3% of net sales, in the third quarter of 2012. The decrease was due to $6.3 million of acquisition expense related to the Sunquest acquisition in the prior year quarter, offset in part by higher equity compensation (as a result of higher stock prices) and other compensation related costs in the current year quarter.

Interest expense in the third quarter of 2013 was $24.7 million as compared to $16.5 million in the third quarter of 2012, due to higher average debt balances related to acquisitions, offset in part by lower average interest rates.

Other income in the third quarter of 2013 was $0.4 million as compared to other expense of $1.4 million in the third quarter of 2012.  Other income and expense in both 2013 and 2012 were due primarily to foreign exchange losses and gains at our non-U.S. based companies.

Our third quarter effective income tax rate was 30.1% as compared to the prior year rate of 29.0%. The increase is due to increased revenues and resulting pretax income in higher tax jurisdictions, primarily the United States.
 
At September 30, 2013, the functional currencies of our European subsidiaries were stronger and the Canadian dollar was weaker against the U.S. dollar compared to currency exchange rates at June 30, 2013. The currency changes resulted in a pre-tax increase of $33.7 million in the foreign exchange component of comprehensive earnings for the current year quarter. Approximately $17 million of the total adjustment is related to goodwill and does not directly affect our expected future cash flows. During the quarter ended September 30, 2013 the Canadian dollar and British pound were weaker, and the functional currencies of our other European subsidiaries were stronger against the U.S. dollar as compared to the quarter ended September 30, 2012.  The difference between the operating profits for these companies for the third quarter of 2013 compared to the prior year quarter, translated into U.S. dollars, was approximately 1%.

Net orders were $838.3 million for the third quarter of 2013, $118.5 million higher than the third quarter 2012 net order intake of $719.7 million.  Organic growth contributed 7%, and acquisitions contributed 10% to the current quarter orders. Overall, our order backlog at September 30, 2013 was up 7% as compared to September 30, 2012.

 
 
Net orders booked for the
three months ended
September 30,
 
Order backlog as of September 30,
 
 
 
2013
 
2012
 
2013
 
2012
 
Industrial Technology
 
$
197,549
 
$
191,955
 
$
131,768
 
$
143,808
 
Energy Systems & Controls
 
 
148,922
 
 
147,304
 
 
120,415
 
 
118,510
 
Medical & Scientific Imaging
 
 
262,320
 
 
177,528
 
 
276,926
 
 
243,749
 
RF Technology
 
 
229,484
 
 
202,959
 
 
515,683
 
 
472,342
 
 
 
$
838,275
 
$
719,746
 
$
1,044,792
 
$
978,409
 


Nine months ended September 30, 2013 compared to nine months ended September 30, 2012

Net sales for the nine months ended September 30, 2013 were $2.3 billion as compared to $2.2 billion in the prior year nine month period, an increase of 8%.  The increase was due primarily to acquisitions, offset in part by a small negative impact from foreign currency.

In our Industrial Technology segment, net sales decreased by 3% to $580.5 million in the first nine months of 2013 as compared to $598.1 million in the first nine months of 2012.  The decrease was due primarily to the loss of a customer at our water metering business and lower sales at our materials testing business.  Gross margins were 51.1% for the first nine months of 2013 as compared to 50.8% in the first nine months of 2012 due primarily to product mix.  SG&A expenses as a percentage of net sales were 22.8%, as compared to 20.7% in the prior year nine month period, due primarily to a $9.1 million pretax charge for warranty expense at one of our subsidiaries, Hansen Technologies, to provide its customers with replacements for refrigeration valves that included a vendor-supplied component that did not meet Roper quality standards.  The resulting operating profit margins were 28.3% in the first nine months of 2013 as compared to 30.1% in the first nine months of 2012.

Net sales in our Energy Systems & Controls segment decreased by 1% to $456.0 million during the first nine months of 2013 compared to $461.5 million in the first nine months of 2012, due to lower sales of pressure sensors for industrial applications and non-destructive testing systems for nuclear plants which was offset in part by increased demand for control systems for oil and gas applications.  Gross margins were 56.2% in the first nine months of 2013, compared to 55.1% in the first nine months of 2012, due to product mix. SG&A expenses as a percentage of net sales were 30.3% as compared to 29.4% in the prior year nine month period due to product mix. Operating margins were 26.0% in the first nine months of 2013 as compared to 25.7% in first nine months of 2012.

In our Medical & Scientific Imaging segment, net sales increased 33% to $645.7 million in the first nine months of 2013 as compared to $486.2 million in the first nine months of 2012.  The change was comprised of a 35% increase from acquisitions, negative organic growth of 2%, and a small negative foreign exchange impact.  We experienced continued growth in our medical businesses, which was more than offset by weakness in camera sales into research markets.  Gross margins increased to 68.3% in the first nine months of 2013 from 64.7% in the first nine months of 2012, due to the higher gross margin profile of our acquired businesses. SG&A expenses as a percentage of net sales were 40.5% in the nine month period ended September 30, 2013 as compared to 38.9% in the nine month period ended September 30, 2012 due to SG&A expenses at MHA in which the corresponding revenues were not recognizable under GAAP (see Note 4 of the notes to Condensed Consolidated Financial Statements).  Operating margins were 27.8% in the first nine months of 2013 as compared to 25.8% in the first nine months of 2012.

In our RF Technology segment, net sales were $666.7 million in the first nine months of 2013 compared to $637.8 million in the first nine months of 2012, an increase of 5%. The increase was due primarily to growth in our toll and traffic, university card systems and security solutions businesses. Gross margins in the first nine months of 2013 were 53.4% as compared to 52.2% in the prior year nine month period due to product mix.  SG&A expenses as a percentage of net sales in the first nine months of 2013 were 25.8% as compared to 26.0% in the first nine months of 2012.  Operating profit margins were 27.6% in 2013 as compared to 26.1% in 2012.

Corporate expenses increased by $3.3 million to $61.7 million, or 2.6% of net sales, in the first nine months of 2013 as compared to $58.4 million, or 2.7% of net sales, in the first nine months of 2012. The increase was due to higher equity compensation (as a result of higher stock prices) offset in part by decreased acquisition costs over the prior year nine month period.

Interest expense was $67.9 million for the first nine months of 2013 as compared to $47.0 million for the first nine months of 2012, due to higher average debt balances related to acquisitions, offset in part by lower average interest rates.

Other income in the nine months ended September 30, 2013 was $0.4 million, due primarily to a one-time pretax gain related to a legal settlement offset by foreign exchange losses at our non-U.S. based companies, as compared to other expense of $2.4 million in the nine months ended September 30, 2012, due primarily to foreign exchange losses at our non-U.S. based companies.

Income taxes were 27.9% of pretax earnings in the first nine months of 2013 as compared to 29.5% of pretax earnings in the first nine months of 2012.  The reduction was due to $6 million in discrete tax benefits related to the enactment of the American Taxpayer Relief Act of 2012 ("ATRA"), as well as a $6 million benefit from the adjustment of tax balances which were immaterial to any covered period, offset in part by increased revenues and resulting pretax income in higher tax jurisdictions, primarily the United States.

At September 30, 2013, the Canadian dollar and British pound were weaker, and the functional currencies of our other European subsidiaries were stronger against the U.S. dollar as compared to currency exchange rates at December 31, 2012. The currency changes resulted in a pretax decrease of $11 million in the foreign exchange component of comprehensive earnings for the nine months ended September 30, 2013, $7 million of which was related to goodwill.  Goodwill changes from currency exchange rate changes do not directly affect our reported earnings or cash flows.  During the nine months ended September 30, 2013 the Canadian dollar and British pound were weaker, and the functional currencies of our other European subsidiaries were stronger against the U.S. dollar as compared to the nine months ended September 30, 2012.  The difference between the operating profits for these companies for the nine months ended September 30, 2013 compared to the nine months ended September 30, 2012, translated into U.S. dollars, was approximately 1%.



Financial Condition, Liquidity and Capital Resources

Selected cash flows for the three and nine month periods ended September 30, 2013 and 2012 were as follows (in millions):

 
 
Three months ended September 30,
   
Nine months ended September 30,
 
 
 
2013
   
2012
   
2013
   
2012
 
Cash provided by/(used in):
 
   
   
   
 
Operating activities
 
$
255.8
   
$
205.4
   
$
566.8
   
$
466.2
 
Investing activities
   
(18.6
)
   
(1,417.3
)
   
(1,046.7
)
   
(1,474.1
)
Financing activities
   
(161.4
)
   
1,039.6
     
569.5
     
1,020.0
 
 
Operating activities - Net cash provided by operating activities in the third quarter of 2013 was $50.3 million higher than the third quarter of 2012, due primarily to improved receivables collection and increased earnings net of intangible amortization related to acquisitions.   In the nine month period ending September 30, 2013, operating cash flow increased $100.6 million over the prior year nine month period due to improved receivables collection and increased earnings net of intangible amortization related to acquisitions.

Investing activities - Cash used in investing activities during the three and nine month periods ended September 30, 2013 and 2012 was primarily for business acquisitions and capital expenditures.

Financing activities - Cash used in financing activities in the third quarter of 2013 was for the repayment of our $500 million of senior notes which matured on August 15, 2013, offset in part by revolver borrowings used to repay the notes.  Cash provided by financing activities in the third quarter of 2012 was for revolver borrowings offset partially by dividends and principal debt payments.

Cash provided by financing activities in the nine month period ended September 30, 2013 was primarily for principal debt borrowings for acquisitions, offset in part by principal debt payments and dividends.  Cash provided by financing activities in the nine month period ended September 30, 2012 was from revolver borrowings offset partially by dividends and principal debt payments.

Total debt at September 30, 2013 consisted of the following (amounts in thousands):

$400 million senior notes due 2017
 
$
400,000
 
$800 million senior notes due 2018
   
800,000
 
$500 million senior notes due 2019
   
500,000
 
$500 million senior notes due 2022
   
500,000
 
Senior Subordinated Convertible Notes
   
9,770
 
Revolving Facility
   
390,000
 
Other
   
6,087
 
Total debt
   
2,605,857
 
Less current portion
   
12,250
 
Long-term debt
 
$
2,593,607
 

The interest rate on borrowings under our $1.5 billion credit facility is calculated based upon various recognized indices plus a margin as defined in the credit agreement. At September 30, 2013, there were $390 million of outstanding borrowings under the facility.  At September 30, 2013, we had $6.1 million of other debt in the form of capital leases, several smaller facilities that allow for borrowings or the issuance of letters of credit in various foreign locations to support our non-U.S. businesses and $40 million of outstanding letters of credit.

On June 6, 2013, we completed a public offering of $800 million aggregate principal amount of 2.05% senior unsecured notes due 2018. See Note 8 of the Notes to Condensed Consolidated Financial Statements for additional information regarding the notes.

The cash and short-term investments at our foreign subsidiaries at September 30, 2013 totaled $357 million.  Repatriation of these funds under current regulatory and tax law for use in domestic operations would expose us to additional taxes.  We expect existing cash and cash equivalents, cash generated by our U.S. operations, our unsecured credit facility, as well as our expected ability to access the capital markets, will be sufficient to fund operating requirements in the U.S. for the foreseeable future.

We were in compliance with all debt covenants related to our credit facilities throughout the nine months ended September 30, 2013.

Net working capital (total current assets, excluding cash, less total current liabilities, excluding debt) was $307.3 million at September 30, 2013 compared to $307.8 million at December 31, 2012, reflecting decreased working capital due primarily to increases in deferred revenue and MHA revenue-share obligations offset in part by increases in deferred tax assets related primarily to the MHA acquisition.
 

Total debt was $2.61 billion at September 30, 2013 compared to $2.02 billion at December 31, 2012 due to borrowings to fund acquisitions offset in part by the use of operating cash flows to reduce outstanding debt.  Our leverage is shown in the following table (in thousands):
 
 
 
September 30,
2013
 
 
December 31,
2012
Total debt
 
$
2,605,857
 
 
$
2,022,122
 
Cash
 
 
(459,980
)
 
 
(370,590
)
Net debt
 
 
2,145,877
 
 
 
1,651,532
 
Stockholders' equity
 
 
4,062,813
 
 
 
3,687,726
 
Total net capital
 
$
6,208,690
 
 
$
5,339,258
 
 
 
 
 
 
 
 
 
 
Net debt / Total net capital
 
 
34.6
%
 
 
30.9
%

At September 30, 2013, we did not have any relationships with unconsolidated entities or financial partnerships, such as entities often referred to as structured finance or special purpose entities, which would have been established for the purpose of facilitating off-balance sheet arrangements or other contractually narrow or limited purposes.

Capital expenditures of $33.3 million and $29.2 million were incurred during the nine months ended September 30, 2013 and 2012, respectively. We expect capital expenditures for the balance of the year to be comparable to prior years as a percentage of sales.


Outlook

Current geopolitical uncertainties could adversely affect our business prospects. A significant terrorist attack or other global conflict could cause changes in world economies that would adversely affect us. It is impossible to isolate each of these factor's effects on current economic conditions. It is also impossible to predict with any reasonable degree of certainty what or when any additional events may occur that also will similarly disrupt the economy.

We maintain an active acquisition program; however, future acquisitions will be dependent on numerous factors and it is not feasible to reasonably estimate if or when any such acquisitions will occur and what the impact will be on our business, financial condition and results of operations. Such acquisitions may be financed by the use of existing credit lines, future cash flows from operations, the proceeds from the issuance of new debt or equity securities or some combination of these methods.

We anticipate that our businesses will generate positive cash flows from operating activities, and that these cash flows will permit the reduction of outstanding debt. However, the rate at which we can reduce our debt during 2013 (and reduce the associated interest expense) will be affected by, among other things, the financing and operating requirements of any new acquisitions and the financial performance of our existing companies; and none of these factors can be predicted with certainty.



ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

See "Item 7A - Quantitative and Qualitative Disclosures about Market Risk," in our 2012 Annual Report on Form 10-K. There were no material changes during the three or nine month periods ended September 30, 2013.



ITEM 4.                            CONTROLS AND PROCEDURES
As required by SEC rules, we have evaluated the effectiveness of the design and operation of our disclosure controls and procedures as of the end of the period covered by this quarterly report ("Evaluation Date"). This evaluation was carried out under the supervision and with the participation of our management, including our principal executive officer and principal financial officer. Based on this evaluation as of the Evaluation Date, these officers have concluded that the design and operation of our disclosure controls and procedures are effective.
Our disclosure controls and procedures are designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), is recorded, processed, summarized and reported, within the time periods specified in the SEC's rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act are accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure.
There were no changes to our internal controls during the period covered by this quarterly report that materially affected, or are reasonably likely to materially affect, our internal controls over financial reporting.


Part II.                                        OTHER INFORMATION


Item 1.                                        Legal Proceedings

Information pertaining to legal proceedings can be found in Note 10 of the Notes to Condensed Consolidated Financial Statements included elsewhere in this report, and is incorporated by reference herein.


Item 1A.                          Risk Factors

For information regarding factors that could affect our results of operations, financial condition and liquidity, see the risk factors discussion in Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2012 as filed on February 25, 2013 with the SEC. See also, "Information about Forward-Looking Statements" included in Part I, Item 2 of this Quarterly Report on Form 10-Q.


Item 6.                                        Exhibits

31.1
Rule 13a-14(a)/15d-14(a), Certification of the Chief Executive Officer, filed herewith.
 
 
31.2
Rule 13a-14(a)/15d-14(a), Certification of the Chief Financial Officer, filed herewith.
 
 
32.1
Section 1350 Certification of the Chief Executive and Chief Financial Officers, filed herewith.
 
 
101.INS
XBRL Instance Document, furnished herewith.
 
 
101.SCH
XBRL Taxonomy Extension Schema Document, furnished herewith.
 
 
101.CAL
XBRL Taxonomy Extension Calculation Linkbase Document, furnished herewith.
 
 
101.DEF
XBRL Taxonomy Extension Definition Linkbase Document, furnished herewith.
 
 
101.LAB
XBRL Taxonomy Extension Label Linkbase Document, furnished herewith.
 
 
101.PRE
XBRL Taxonomy Extension Presentation Linkbase Document, furnished herewith.



Signatures

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


Roper Industries, Inc.


/s/ Brian D. Jellison
 
Chairman of the Board, President,
November 8, 2013
Brian D. Jellison
 
and Chief Executive Officer
 
 
 
(Principal Executive Officer)
 


/s/ John Humphrey
 
Chief Financial Officer and
November 8, 2013
John Humphrey
 
Executive Vice President
 
 
 
(Principal Financial Officer)
 


/s/ Paul J. Soni
 
Vice President and Controller
November 8, 2013
Paul J. Soni
 
(Principal Accounting Officer)
 




EXHIBIT INDEX
TO REPORT ON FORM 10-Q


Number                                                                            Exhibit

31.1
Rule 13a-14(a)/15d-14(a), Certification of the Chief Executive Officer, filed herewith.
 
 
31.2
Rule 13a-14(a)/15d-14(a), Certification of the Chief Financial Officer, filed herewith.
 
 
32.1
Section 1350 Certification of the Chief Executive and Chief Financial Officers, filed herewith.
 
 
101.INS
XBRL Instance Document, furnished herewith.
 
 
101.SCH
XBRL Taxonomy Extension Schema Document, furnished herewith.
 
 
101.CAL
XBRL Taxonomy Extension Calculation Linkbase Document, furnished herewith.
 
 
101.DEF
XBRL Taxonomy Extension Definition Linkbase Document, furnished herewith.
 
 
101.LAB
XBRL Taxonomy Extension Label Linkbase Document, furnished herewith.
 
 
101.PRE
XBRL Taxonomy Extension Presentation Linkbase Document, furnished herewith.